Seems extremely unlikely that a loan scenario would include an additional 100M shares when JT and crew are trying to get all of Elite's Preferred shares converted to common shares....not to mention how many shares JT and the rest of the board own. Additionally, given that the default Socius deal only included 50M shares seems more than a stretch to conceive of an additional 100M shares.
Now as we know the Socius deal was prior to Elite receiving the Eli 216 patent for all opioids and given this fact, it would be much more likely that Elite partners with a Big Pharma company that does not add dilution IMO. Say how Mikah/Actavis gave us Naltrexone and in lieu of the $200,00 allowed Elite to provide R&D services for them.
Market Data 
Markets 
AI
